US Broker Ratings

Cidara Therapeutics, Inc. (CDTX) Stock Analysis: What Investors Need to Know About This Biotech Contender

As part of the burgeoning biotechnology sector, Cidara Therapeutics, Inc. (CDTX) has carved out a niche in the healthcare industry with its innovative approaches to combating serious diseases. Based in..

Benitec Biopharma Inc. (BNTC) Stock Analysis: Exploring a Potential 101% Upside in the Biotech Sector

Benitec Biopharma Inc. (NASDAQ: BNTC) is emerging as a compelling player in the healthcare sector, specifically within the biotechnology industry. With its headquarters in Hayward, California, this clinical-stage company is..

TotalEnergies SE (TTE) Stock Analysis: Navigating the Energy Giant’s Potential with a 5.92% Dividend Yield

TotalEnergies SE (TTE), a multinational energy powerhouse, operates across a wide spectrum of the energy sector, from traditional oil and gas to innovative renewables. Headquartered in Courbevoie, France, this integrated..

TruBridge, Inc. (TBRG) Stock Analysis: Gauging Growth Prospects in Healthcare IT with a Forward P/E of 9.79

TruBridge, Inc. (NASDAQ: TBRG) is carving a niche in the healthcare sector with its robust suite of health information services. Operating from Mobile, Alabama, TruBridge, formerly known as Computer Programs..

Absci Corporation (ABSI) Stock Analysis: Exploring a 104% Potential Upside in Biotechnology

For investors seeking opportunities in the rapidly evolving biotechnology sector, Absci Corporation (NASDAQ: ABSI) presents an intriguing proposition. With a market capitalization of $596.97 million, this US-based company is at..

Rigel Pharmaceuticals, Inc. (RIGL) Stock Analysis: Exploring a 20% Upside Potential in the Biotech Sector

Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) stands at a compelling crossroads for investors, as the company continues to make significant strides in the biotechnology sector. With a market capitalization of $748.2..

Nano-X Imaging Ltd (NNOX) Stock Analysis: A Potential 138% Upside in the Healthcare Sector

Nano-X Imaging Ltd (NASDAQ: NNOX), a promising player in the healthcare sector, stands out with its innovative approach to medical imaging. As a company focused on transforming the landscape of..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: A 19% Potential Upside Attracts Investor Attention

Investors eyeing the healthcare sector might find Healthcare Services Group, Inc. (NASDAQ: HCSG) an intriguing proposition, as the company currently presents a potential upside of 19.05%. With a market capitalization..

Teladoc Health, Inc. (TDOC) Stock Analysis: Evaluating the 21.39% Potential Upside for Investors

As Teladoc Health, Inc. (NYSE: TDOC) continues to navigate the complex landscape of the healthcare sector, individual investors are keenly assessing its potential for future growth. With a market capitalization..

Mineralys Therapeutics (MLYS): Investor Outlook Reveals Nearly 30% Upside Potential

Mineralys Therapeutics, Inc. (NASDAQ: MLYS) has emerged as a promising player in the biotechnology sector, captivating investor attention with its ambitious clinical initiatives and impressive stock performance. With a market..

BioLife Solutions, Inc. (BLFS) Stock Analysis: Exploring a 28.66% Upside Potential in the Healthcare Sector

BioLife Solutions, Inc. (NASDAQ: BLFS) is attracting considerable attention from investors, underpinned by a promising 28.66% potential upside. Operating at the forefront of the healthcare sector, BioLife Solutions is a..

Pediatrix Medical Group, Inc. (MD) Stock Analysis: Exploring Potential Upside with Healthcare Specialist

Pediatrix Medical Group, Inc. (NYSE: MD) stands at the forefront of neonatal and maternal-fetal healthcare in the United States, with a market capitalization of $1.88 billion. As a key player..

Evolent Health, Inc (EVH) Growth Potential: Analyst Consensus Points to 159% Upside

Evolent Health, Inc. (NYSE: EVH) is capturing attention across the investment community with its remarkable potential for substantial upside. With analyst ratings overwhelmingly favoring a “Buy” stance, the stock’s projected..

Evotec SE (EVO) Stock Analysis: Evaluating an 83.88% Potential Upside Despite Recent Challenges

For investors keen on exploring opportunities within the healthcare sector, Evotec SE (EVO), a prominent player in the drug discovery and development industry, presents a fascinating case. Situated in Hamburg,..

Novavax, Inc. (NVAX) Investor Outlook: Exploring an 86.82% Potential Upside in the Biotechnology Sector

Novavax, Inc. (NASDAQ: NVAX), a prominent player in the biotechnology sector, has recently captured the attention of investors with its compelling potential upside of 86.82%, despite facing significant challenges. As..

Liquidia Corporation (LQDA) Stock Analysis: Exploring a Potential 25.68% Upside in the Biotech Sector

For investors keen on the biotechnology sector, Liquidia Corporation (NASDAQ: LQDA) presents an intriguing opportunity with a potential upside of 25.68% according to current analyst ratings. As a biopharmaceutical company,..

Amphastar Pharmaceuticals (AMPH) Stock Analysis: Uncovering a 21.93% Potential Upside

Investors eyeing the healthcare sector should pay close attention to Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a dynamic player in the specialty and generic drug manufacturing industry. Despite recent market volatility,..

agilon health, inc. (AGL) Stock Analysis: Navigating a 39% Potential Upside in Healthcare

agilon health, inc. (AGL) represents an intriguing prospect within the healthcare sector, specifically in the medical care facilities industry. Headquartered in Westerville, Ohio, the company focuses on providing healthcare services..

Azenta, Inc. (AZTA) Stock Analysis: Unveiling a 13.65% Potential Upside Amidst Steady Growth

Azenta, Inc. (NASDAQ: AZTA), a key player in the healthcare sector’s medical instruments and supplies industry, has caught the eye of investors with its potential upside of 13.65%. With a..

Arcutis Biotherapeutics, Inc. (ARQT) Stock Analysis: Evaluating the 121.70% Revenue Growth in the Booming Biotech Market

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) stands out in the biotechnology sector with its remarkable revenue growth and innovative approach to dermatological treatments. Headquartered in Westlake Village, California, this promising biopharmaceutical..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds